Adam Koppel Cerevel Therapeutics Holdings, Inc. (CERE) insider trading activity

CERE Quotes by TradingView

Adam Koppel is of Cerevel Therapeutics Holdings, Inc.. Currently has a direct ownership of 13,743 shares of CERE, which is worth approximately $613,212. The most recent transaction as insider was on Jun 05, 2024, when has been sold 10,461 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.7K
318.74% 3M change
318.74% 12M change
Total Value Held $613,212

Adam Koppel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2024
BUY
Grant, award, or other acquisition
-
10,461 Added 43.22%
13,743 Common Stock
Jun 07 2023
BUY
Grant, award, or other acquisition
-
3,282 Added 50.0%
3,282 Common Stock

Also insider at

APTX
Aptinyx Inc. Healthcare
Director
BLSA
BCLS Acquisition Corp. Financial Services
Director
SLDB
Solid Biosciences Inc. Healthcare
DRNA
Dicerna Pharmaceuticals Inc
Director
FHTX
Foghorn Therapeutics Inc. Healthcare
AK

Adam Koppel

Boston, MA

Track Institutional and Insider Activities on CERE

Follow Cerevel Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CERE shares.

Notify only if

Insider Trading

Get notified when an Cerevel Therapeutics Holdings, Inc. insider buys or sells CERE shares.

Notify only if

News

Receive news related to Cerevel Therapeutics Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CERE